Law360, New York (December 07, 2007) -- Four years and a few antitrust claims after it was filed, Medtronic Inc.'s coronary stent patent suit is gearing up for trial with a list of what Medtronic wants the Dallas court to prevent Cordis Corp. from mentioning in the courtroom.
When Minnesota-based Medtronic first filed the suit back in 2003, it slammed the Florida-based Johnson & Johnson subsidiary with accusations that it had illegally tied the purchase of its drug-eluting...
